Moody's: Gilead unchanged

Moody's Investors Service said there is currently no impact on the Baa1 rating of Gilead Sciences, Inc. resulting from Gilead's recent subpoena from U.S. Attorney's Office for the Northern District of California.

The outlook is stable.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.